- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.96 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x Z07: 4-(trifluoromethyl)-1,3-benzothiazol-2-amine(Non-covalent)
- 1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 5 residues within 4Å:- Chain A: I.21, Q.25, V.29, Y.32
- Chain B: S.28
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:I.21, A:V.29, A:Y.32
- Hydrogen bonds: A:Q.25, B:S.28
ACT.11: 6 residues within 4Å:- Chain B: H.173, P.176
- Chain C: S.168, K.169, Q.170, A.176
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:H.173
- 4 x CAD: CACODYLIC ACID(Non-covalent)
CAD.5: 5 residues within 4Å:- Chain B: S.66, R.67, V.68, T.69, S.84
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.69, B:S.84
CAD.6: 6 residues within 4Å:- Chain B: W.34, E.51, N.59, S.100
- Chain C: W.91, W.98
No protein-ligand interaction detected (PLIP)CAD.7: 4 residues within 4Å:- Chain B: L.106, D.110, Y.111
- Chain C: P.55
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain B- Water bridges: C:L.46
- Hydrogen bonds: B:D.110
CAD.16: 9 residues within 4Å:- Chain B: G.43, K.44
- Chain C: P.7, D.85, Y.87, G.102, G.103, T.104, K.105
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:G.103, C:K.105
- 4 x P15: 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL(Non-covalent)
P15.8: 5 residues within 4Å:- Chain B: Q.3, L.4, Q.5, A.23, S.25
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.25
P15.10: 10 residues within 4Å:- Chain B: V.93, Y.95, Q.114, G.115, L.117
- Chain C: Q.38, L.39, P.40, G.41, D.85
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:G.41
- Water bridges: B:L.117
P15.12: 2 residues within 4Å:- Chain B: N.208, K.215
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.208, B:K.215
P15.18: 6 residues within 4Å:- Chain C: Q.37, K.45, L.46, S.56, G.57, P.59
No protein-ligand interaction detected (PLIP)- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.9: 2 residues within 4Å:- Chain B: T.58, N.59
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.59
- Water bridges: B:T.58
EDO.13: 2 residues within 4Å:- Chain B: R.39, L.64
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.39
EDO.14: 5 residues within 4Å:- Chain C: S.30, N.31, Y.32, N.51, K.66
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:S.30, C:N.51, C:K.66
EDO.15: 4 residues within 4Å:- Chain B: V.178, L.179
- Chain C: E.163, T.164
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:E.163, C:T.164, C:T.164, B:L.179
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Davies, C.W. et al., Conformation-locking antibodies for the discovery and characterization of KRAS inhibitors. Nat.Biotechnol. (2022)
- Release Date
- 2022-03-16
- Peptides
- Isoform 2B of GTPase KRas: A
IgG heavy chain: B
IgG light chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
HC
I
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.96 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x Z07: 4-(trifluoromethyl)-1,3-benzothiazol-2-amine(Non-covalent)
- 1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 4 x CAD: CACODYLIC ACID(Non-covalent)
- 4 x P15: 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL(Non-covalent)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Davies, C.W. et al., Conformation-locking antibodies for the discovery and characterization of KRAS inhibitors. Nat.Biotechnol. (2022)
- Release Date
- 2022-03-16
- Peptides
- Isoform 2B of GTPase KRas: A
IgG heavy chain: B
IgG light chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
HC
I